Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat. (Q43109238)

14 November 2017

title

Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat. (English)

1 reference

14 November 2017

0 references

Amir H Dorafshar

1 reference

14 November 2017

Kogie Moodley

1 reference

14 November 2017

Michelle Khoe

1 reference

14 November 2017

Chris Lyon

1 reference

14 November 2017

Michael Bryer-Ash

1 reference

14 November 2017

language of work or name

English

0 references

publication date

13 October 2009

1 reference

Diabetes and Vascular Disease Research

14 November 2017

published in

1 reference

14 November 2017

1 reference

14 November 2017

1 reference

14 November 2017

page(s)

20-27

1 reference

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Role of endothelial dysfunction in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Insulin resistance and endothelial dysfunction in atherosclerosis: implications and interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Insulin resistance and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Investigation of endothelial hyperreactivity in the obese Zucker rat in-situ: reversal by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Investigation of oxidant stress and vasodepression to glyceryl trinitrate in the obese Zucker rat in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Insulin resistance and its treatment by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

PPAR gamma and the treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The effect of CP 68,722, a thiozolidinedione derivative, on insulin sensitivity in lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Thiazolidinediones, peroxisome proliferator-activated receptor gamma agonists, regulate endothelial cell growth and secretion of vasoactive peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Vascular protective effects by activation of nuclear receptor PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Evaluation of hemodynamics, vascular reactivity and baroreceptor compensation in the insulin resistant Zucker obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Effect of sodium orthovanadate treatment on cardiovascular function in the hyperinsulinemic, insulin-resistant obese Zucker rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Antihypertensive effects of CS-045 treatment in obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The L-arginine-nitric oxide pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Superoxide and peroxynitrite in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109341688

21 January 2018

Identifiers

DOI

10.1177/1479164109341688

1 reference

14 November 2017

1 reference